Akari Therapeutics Plc
AKTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001541157
No open-market purchases or sales by Akari Therapeutics Plc insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $1.54M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Akari Therapeutics Plc as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- +5 vs. Q3 2025
- Shares held
- 4.45M
- +3.28M (+280.6%) vs. Q3 2025
- Total value
- $1.29M
- +$105.4K (+8.9%) vs. Q3 2025
- New holders
- 9
- 3 more added
- Sold out
- 4
- 2 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AKTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 9 | $1.54M |
| Q1 2026 | 6 | $308.2K |
| Q4 2025 | 21 | $1.29M |
| Q3 2025 | 16 | $1.18M |
| Q2 2025 | 15 | $644.3K |
| Q1 2025 | 11 | $377.3K |
| Q4 2024 | 14 | $393.8K |
| Q3 2024 | 10 | $535.9K |
| Q2 2024 | 10 | $488.1K |
| Q1 2024 | 8 | $326.3K |
| Q4 2023 | 9 | $891.6K |
| Q3 2023 | 8 | $1.19M |
| Q2 2023 | 16 | $1.71M |
| Q1 2023 | 12 | $1.84M |
| Q4 2022 | 15 | $4.19M |
| Q3 2022 | 14 | $6.37M |
| Q2 2022 | 14 | $1.68M |
| Q1 2022 | 11 | $1.89M |
| Q4 2021 | 11 | $2.16M |
| Q3 2021 | 14 | $1.99M |
| Q2 2021 | 12 | $2.27M |
| Q1 2021 | 15 | $3.90M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Akari Therapeutics Plc; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 3 | $1 | 0.00% | 00.0% | Unchanged |
| Cornerstone Planning Group LLC | 5 | $1 | 0.00% | −2−28.6% | Reduced |
| Truvestments Capital LLC | 50 | $14 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 200 | $58 | 0.00% | +200 | New |
| Bank of America Corp | 410 | $118 | 0.00% | +260+173.3% | Added |
| Accent Capital Management, LLC | 5,000 | $1.45K | 0.00% | −5,000−50.0% | Reduced |
| GWM Advisors LLC | 6,800 | $1.97K | 0.00% | 00.0% | Unchanged |
| Independent Advisor Alliance | 17,075 | $4.93K | 0.00% | +6,188+56.8% | Added |
| Skyview Financial Group LLC | 20,575 | $5.95K | 0.01% | +20,575 | New |
| StoneX Group Inc. | 21,295 | $6.15K | 0.00% | +21,295 | New |
| Cerity Partners LLC | 23,643 | $6.83K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 32,855 | $9.50K | 0.00% | +32,795+54,658.3% | Added |
| XTX Topco Ltd | 49,019 | $14.2K | 0.00% | +49,019 | New |
| CWA Asset Management Group, LLC | 55,000 | $15.9K | 0.00% | +55,000 | New |
| SmartHarvest Portfolios, LLC | 69,248 | $20.0K | 0.01% | +69,248 | New |
| Jane Street Group, LLC | 71,644 | $20.7K | 0.00% | +71,644 | New |
| HighTower Advisors, LLC | 79,236 | $22.9K | 0.00% | 00.0% | Unchanged |
| Palo Alto Investors LP | 146,024 | $42.2K | 0.01% | 00.0% | Unchanged |
| Warberg Asset Management LLC | 308,340 | $88.7K | 0.03% | +308,340 | New |
| Cresset Asset Management, LLC | 822,468 | $237.7K | 0.00% | 00.0% | Unchanged |
| Armistice Capital, LLC | 2,723,966 | $787.2K | 0.02% | +2,723,966 | New |
| Omnia Family Wealth, LLC | 0 | $0 | 0.00% | −28,440−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −22,502−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −19,753−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −44−100.0% | Sold out |